BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Clinical Oncology

The World Journal of Clinical Oncology (WJCO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of oncology.  It was launched on November 10, 2010 and is published bimonthly (6 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage oncologists worldwide to submit manuscripts to the WJCO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJCO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJCO’s acceptance rate: 55%. Submit here >>

2018 Published Issues
7 6 5 4 3 2 1
  • Hiten RH Patel, BM BCh, BSc, FRCS (Hon), PhD, Professor, Surgical Oncologist, (Email: hrhpatel@hotmail.com)Department of Urology, University Hospital North Norway (UNN), Tromso 9038, Norway
WJCO is now abstracted and indexed in PubMed, PubMed Central, Scopus, and Emerging Sources Citation Index (Web of Science), China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and Superstar Journals Database.
Journal Metrics
IPP (Impact per Publication) (2015): 3.306; SNIP (Source Normalized Impact per Paper) (2015): 1.241; CiteScore (2016): 4.00.
2218-4333 (online)
Basic Study
Lymphocyte subsets predictive value and possible involvement of human papilloma virus infection on breast cancer molecular subtypes 
Andreína Fernandes, Adriana Pesci-Feltri, Isabel García-Fleury, Marco López, Vincent Guida, Marisol De Macedo, María Correnti 
World J Clin Oncol 9(7):123-132. Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.123
Case Control Study
Mismatch repair protein expression and intratumoral budding in rectal cancer are associated with an increased pathological complete response to preoperative chemoradiotherapy: A case-control study 
Leonardo S Lino-Silva, Armando Gamboa-Domínguez, Diego Zúñiga-Tamayo, Rosa A Salcedo-Hernández, Lucely Cetina, David Cantú-de-León 
World J Clin Oncol 9(7):133-139. Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.133
Retrospective Cohort Study
Interconversion of two commonly used performance tools: An analysis of 5844 paired assessments in 1501 lung cancer patients 
Kuruswamy Thurai Prasad, Harpreet Kaur, Valliappan Muthu, Ashutosh Nath Aggarwal, Digambar Behera, Navneet Singh 
World J Clin Oncol 9(7):140-147. Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.140
Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data 
Guo-Jun Tong, Gui-Yang Zhang, Jian Liu, Zhao-Zheng Zheng, Yan Chen, Ping-Ping Niu, Xu-Ting Xu 
World J Clin Oncol 9(7):148-161. Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.148
Case Report
Giant exophytic renal angiomyolipoma masquerading as a retroperitoneal liposarcoma: A case report and review of literature 
Gopal Sharma, Ayush Jain, Prerit Sharma, Sonal Sharma, Vinita Rathi, Pankaj Kumar Garg 
World J Clin Oncol 9(7):162-166. Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.162